Navigation Links
Rosetta Genomics Announces Exercise and Closing of Underwriter's Over-Allotment Option
Date:8/29/2012

PHILADELPHIA and REHOVOT, Israel, Aug. 29, 2012 /PRNewswire/ -- Rosetta Genomics Ltd. ("Rosetta") (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced the sale of an additional 825,000 ordinary shares pursuant to the exercise by the underwriter of the over-allotment option granted to the underwriter in connection with Rosetta's recent public offering of 5.5 million ordinary shares at a price to the public of $5.00 per share.  The gross proceeds to Rosetta from the offering, including the exercise of the over-allotment option, were approximately $31.6 million, before deducting underwriting discounts and commissions and other offering expenses payable by Rosetta.

Aegis Capital Corp. acted as the sole book-running manager for the offering.

A registration statement on Form F-1 relating to the shares was filed with the Securities and Exchange Commission (the "SEC") and was declared effective on August 2, 2012.
A final prospectus relating to the offering has been filed with the SEC and is available on the SEC's website at http://www.sec.gov.
Copies of the final prospectus relating to the offering may be obtained from the offices of Aegis Capital Corp., Prospectus Department, 810 Seventh Avenue, 18th Floor, New York, NY, 10019, telephone: 212-813-1010 or email: prospectus@aegiscap.com, or from the above-mentioned SEC website.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Rosetta Geno
'/>"/>

SOURCE Rosetta Genomics Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Frost & Sullivan Recognizes Rosetta Genomics for Its Strategic Excellence and Strong Contribution to Next-Generation Diagnostics
2. Empire Genomics Chooses Funakoshi as Japan Distributor
3. Rubicon Genomics Launches ThruPLEX™ Family of Sample Preparation Products for Next Generation Sequencing Applications
4. Gentris Corporation Launches New Pharmacogenomics Services
5. Life Technologies Signs Collaborative Agreement with Structural Genomics Consortium to Develop First Antibody Master Set for Epigenetic Studies
6. Life Technologies Acquires Pinpoint Genomics and CLIA-Approved Lung Cancer Test
7. Elsevier Launches New Open Access Journal: Applied and Translational Genomics
8. AbGenomics International Obtains FDA Agreement on Its Phase 2 Clinical Trial Plans
9. Epigenomics Presents Significant Opportunities for Investment and Product Development, According to New Biotech Market Research
10. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
11. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 , Joint ... Ra from Biostar , Published in ,Stem Cells ... of lifespan through multiple IV administration of Adipose-derived MSC ... life expectancy found , Commercialization within 5 years ... the possibility that adult mesenchymal stem cells (MSCs) may ...
(Date:8/27/2015)... Va. , Aug. 27, 2015  The ... the Food and Drug Administration,s (FDA,s) draft guidance ... reference products and biosimilars, to bear a nonproprietary ... AMCP has been seeking a decision from the ... 18 diverse health care stakeholders urging the agency ...
(Date:8/27/2015)... August 27, 2015 According to a new ... Toilet, Seating, Universal, Standing, Bariatric ), Material (Nylon, Padded, Canvas), Usage ... 2020", published by MarketsandMarkets, the Medical Lifting Sling Market is poised ... in 2015, at a CAGR of 11.4 % from 2015 to ... ma rket data T ables and 65 ...
Breaking Medicine Technology:Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4
... Stryker Corporation (NYSE: SYK ) announced that it ... at 4:30 p.m., Eastern Time, to discuss the Company,s operating ... an operational update. Operating results for the quarter ended September ... To participate in the conference call dial 866-270-6057(domestic) ...
... INDIANAPOLIS, Sept. 13 Roche Diagnostics (SIX: RO, ... 510(k) clearance from the U.S. Food and Drug ... modular analyzer series, a Serum Work Area solution ... 3-15 million clinical chemistry / immunochemistry ...
Cached Medicine Technology:Stryker to Host Conference Call on October 19, 2010 2Roche Receives FDA Clearance for U.S. Launch of cobas 8000 Modular Analyzer Series for High-Volume Laboratory Testing 2Roche Receives FDA Clearance for U.S. Launch of cobas 8000 Modular Analyzer Series for High-Volume Laboratory Testing 3
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional Products International ( http://www.nutricompany.com ... of global cosmeceutical and skin care brands. Mr. Fernandez comes with a ... years working in operations, purchasing and management for some of the nations biggest ...
(Date:8/29/2015)... ... August 30, 2015 , ... Rio Salado College President ... the college’s Vice President of Strategic Initiatives and Information Services. O’Shea, who has served ... college expand its reach and impact through innovative technologies and strategies. , “I am ...
(Date:8/29/2015)... ... ... On Saturday, September 19, 2015, Diane Blackburn-Zambetti, the Director of Policy and Prevention ... educational program titled “Asbestos and Your Health.” , The two and one half hour ... at Calvary United Methodist Church, 16 E Park Ave., Ambler, PA 19002. , This ...
(Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, made possible ... lives of patients, according to a newly published report. Surviving Mesothelioma has more ... article. , The authors of the new paper focus on several types ...
(Date:8/29/2015)... ... ... Next weekend is Labor Day weekend, the last bash of the season ... year). For IT security personnel, it should also mark the perfect time to make ... than a simple headache. , Joe Caruso, founder and CEO-CTO of Global Digital ...
Breaking Medicine News(10 mins):Health News:NPI Executive Vice President Leads Cosmeceutical Expansion 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4
... the age of 70 suffers from dementia, according to the ... women from all regions of the country. , About 3.4 ... and older, have some form of dementia, the study found. ... from five percent of those aged 71 to 79 to ...
... California will simultaneously open their doors Wednesday to ... cover the,festivities, SAN FRANCISCO, Oct. 30 It,s ... Nurse administrators don,t often,see miniature witches and 3-foot-tall bumblebees, ... 80-year-young ballerinas! But at more,than 150 nursing homes in ...
... their doors,Wednesday to Trick or Treaters and the media ... 30 It,s not every day,pirates and gypsies visit ... and 3-foot tall bumblebees, and little goblins rarely,get to ... 150 nursing homes in California this Halloween, it,s going ...
... Oct. 30 Mylan Inc. (NYSE: MYL ),today ... Vice,President and Global General Counsel. As Global General Counsel, ... the provision of,legal services, counsel and advice globally to ... across the Company. Mr. Haggerty joins Mylan from ...
... good responses in almost half of patients, study found , ... axitinib shows promise for treating people with what,s known as ... typically have a poor response to drug treatment. , Axitinib ... endothelial growth factor receptors 1, 2 and 3. , ...
... Year EPS Outlook for One-time Tax Benefit, CINCINNATI, ... PG ) announced net sales growth of eight ... delivered,mid-single digit or higher sales growth. Organic sales were ... four to six percent target,growth range. The Fabric & ...
Cached Medicine News:Health News:1 in 7 Americans over age 70 has dementia 2Health News:1 in 7 Americans over age 70 has dementia 3Health News:1 in 7 Americans over age 70 has dementia 4Health News:Halloween Events in the Bay Area Bring Young and Old Together for a Ghoulish Good Time 2Health News:Halloween Events in Eureka, California Bring Young and Old Together for a Ghoulish Good Time 2Health News:Mylan Announces Appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel 2Health News:New Drug Promising Against Tough-to-Treat Kidney Cancer 2Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 2Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 3Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 4Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 5Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 6Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 7Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 8Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 9Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 10Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 11Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 12Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 13Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 14Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 15Health News:P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth 16
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: